These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12213398)

  • 41. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the protective effects of a nanogel-based vaccine against rabbit hepatitis E virus.
    Park BJ; Ahn HS; Han SH; Go HJ; Lee JB; Park SY; Song CS; Lee SW; Paik HJ; Choi YK; Choi IS
    Vaccine; 2019 Sep; 37(40):5972-5978. PubMed ID: 31455586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization of human hepatitis E viruses conferred protection against challenge by a camel hepatitis E virus.
    Guo Y; Yang F; Xu X; Feng M; Liao Y; He Z; Takeda N; Muramatsu M; Li Q; Li TC
    Vaccine; 2020 Oct; 38(46):7316-7322. PubMed ID: 32980200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel linear neutralizing epitope of hepatitis E virus.
    Tang ZM; Tang M; Zhao M; Wen GP; Yang F; Cai W; Wang SL; Zheng ZZ; Xia NS
    Vaccine; 2015 Jul; 33(30):3504-11. PubMed ID: 26051517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus.
    Cai W; Tang ZM; Wen GP; Wang SL; Ji WF; Yang M; Ying D; Zheng ZZ; Xia NS
    Sci Rep; 2016 Apr; 6():25141. PubMed ID: 27122081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission.
    Zhang Y; Zeng H; Liu P; Liu L; Xia J; Wang L; Zou Q; Wang L; Zhuang H
    Vaccine; 2015 Sep; 33(38):4922-8. PubMed ID: 26212003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A.
    Wang K; Zhou L; Zhang X; Song C; Chen T; Li J; Zheng M; Wang Y; Zheng Q; Zheng Z; Yu H; Wu T; Gu Y; Zhang J; Zhao Q; Li S; Xia N
    Antiviral Res; 2019 Apr; 164():154-161. PubMed ID: 30802475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.
    Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM
    J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
    Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
    Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful passive and active immunization of cynomolgus monkeys against hepatitis E.
    Tsarev SA; Tsareva TS; Emerson SU; Govindarajan S; Shapiro M; Gerin JL; Purcell RH
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10198-202. PubMed ID: 7937861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay.
    Emerson SU; Clemente-Casares P; Moiduddin N; Arankalle VA; Torian U; Purcell RH
    J Gen Virol; 2006 Mar; 87(Pt 3):697-704. PubMed ID: 16476993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus.
    Arankalle VA; Chadha MS; Chobe LP
    J Hepatol; 1999 Feb; 30(2):199-204. PubMed ID: 10068096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.
    Su YY; Huang SJ; Guo M; Zhao J; Yu H; He WG; Jiang HM; Wang YJ; Zhang XF; Cai JP; Yang CL; Wang ZZ; Zhu FC; Wu T; Zhang J; Xia NS
    Clin Microbiol Infect; 2017 May; 23(5):336.e1-336.e4. PubMed ID: 27836809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Vaccine; 2016 Feb; 34(7):905-13. PubMed ID: 26778421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of long-persisting human hepatitis E virus antibodies in protection.
    Chauhan A; Dilawari JB; Sharma R; Mukesh M; Saroa SR
    Vaccine; 1998 Apr; 16(7):755-6. PubMed ID: 9562697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies against hepatitis E virus in Old World monkeys.
    Arankalle VA; Goverdhan MK; Banerjee K
    J Viral Hepat; 1994; 1(2):125-9. PubMed ID: 8790567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.